Autoantibodies in Neuropsychiatric Disorders
Little is known about the etiology of neuropsychiatric disorders. The identification of autoantibodies targeting the N-methyl-d-aspartate receptor (NMDA-R), which causes neurological and psychiatric symptoms, has reinvigorated the hypothesis that other patient subgroups may also suffer from an under...
Main Authors: | Carolin Hoffmann, Shenghua Zong, Marina Mané-Damas, Peter Molenaar, Mario Losen, Pilar Martinez-Martinez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-04-01
|
Series: | Antibodies |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4468/5/2/9 |
Similar Items
-
Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?
by: Shenghua Zong, et al.
Published: (2017-07-01) -
Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders
by: Pilar eMartinez-Martinez, et al.
Published: (2013-09-01) -
From Toxins Targeting Ligand Gated Ion Channels to Therapeutic Molecules
by: Antoine Taly, et al.
Published: (2011-03-01) -
Amantadine Improves Delayed Neuropsychiatric Sequelae of Carbon Monoxide Poisoning: A Case Report
by: Tomosuke Nakano, et al.
Published: (2019-10-01) -
Experience-Dependent Changes in Excitatory & Inhibitory Receptor Subunit Expression in Visual Cortex
by: Brett R Beston, et al.
Published: (2010-09-01)